Lung Cancer Outcomes at KFSYSCC
Between 2015-2019, the five-year survival rate for lung cancer at KFSYSCC was 41.1% vs 31.7% for other hospitals in Taiwan.
Basic Information and Distribution of 5,364 Lung Cancer Patients at KFSYSCC from 1990-2019
| Total | 1990-1994 | 1995-1999 | 2000-2004 | 2005-2009 | 2010-2014 | 2015-2019 | |
|---|---|---|---|---|---|---|---|
| n | 5,364 | 127 (2%) | 350 (7%) | 1,141 (21%) | 1,292 (24%) | 1,376 (26%) | 1,078 (20%) |
| Gender (%) | |||||||
| Male | 2,966 (55%) | 81 (64%) | 221 (63%) | 667 (58%) | 715 (55%) | 713 (52%) | 569 (53%) |
| Female | 2,398 (45%) | 46 (36%) | 129 (37%) | 474 (42%) | 577 (45%) | 663 (48%) | 509 (47%) |
| Age | |||||||
| Mean/Median | 62/62 | 63/66 | 62/64 | 61/62 | 62/62 | 62/62 | 61/62 |
| Range | 3-96 | 27-87 | 18-86 | 24-92 | 28-92 | 18-96 | 3-93 |
| Q1-Q3 | 54-70 | 52-73 | 53-71 | 53-71 | 54-71 | 54-71 | 54-69 |
| Stage (%) | |||||||
| 0 | 7 (0.1%) | 0 (0%) | 0 (0%) | 2 (0.2%) | 1 (0.1%) | 1 (0.1%) | 3 (0.3%) |
| I | 785 (15%) | 5 (4%) | 4 (1%) | 73 (6%) | 174 (13%) | 264 (19%) | 265 (25%) |
| II | 234 (4%) | 1 (1%) | 6 (2%) | 36 (3%) | 45 (3%) | 88 (6%) | 58 (5%) |
| III | 1,226 (23%) | 23 (18%) | 76 (22%) | 268 (23%) | 397 (31%) | 272 (20%) | 190 (18%) |
| IV | 2,706 (50%) | 45 (35%) | 120 (34%) | 587 (51%) | 650 (50%) | 749 (54%) | 555 (51%) |
| Unknown | 406 (8%) | 53 (42%) | 144 (41%) | 175 (15%) | 25 (2%) | 2 (0.2%) | 7 (1%) |
Based on KFSYSCC's cancer registry from 1990 to 2019, there were 16,540 analytic breast cancer cases, with 40 males (0.2%) and 16,500 females (99.8%). The average and median ages were 51 and 49 years old, respectively; the youngest patient was 17 years old, and the oldest was 95 years old; the interquartile range (Q1-Q3) was 43-58. By stage, there were 1,889 stage 0 breast cancer patients (11%), 5,162 stage I patients (31%), 5,550 stage II patients (34%), 2,715 stage III patients (16%), and 757 stage IV patients (5%). The basic information and stage distribution of all breast cancer patients, sorted by the year of diagnosis, are presented in the table above.
Survival Curves for 5,364 Lung Cancer Patients (1990-2019), Stratified by Year of Diagnosis
From 1990 to 2019, the chart illustrates the five-year observed survival rates for 5,364 lung cancer patients at KFSYSCC, stratified by the year of diagnosis. The graph shows the five-year survival rate for lung cancer increased from 9% in 1990-1994 to 41% in 2015-2019, while the ten-year survival rate rose from 3% in 1990-1994 to 20% in 2010-2014.
Treatment Methods and Stages for 1,078 Lung Cancer Patients
at KFSYSCC (2015-2019)
| Treatment Type | Total | Stage 0 | Stage I | Stage II | Stage III | Stage IV | Unknown |
|---|---|---|---|---|---|---|---|
| Total | 1,078 | 3 | 265 | 58 | 190 | 555 | 7 |
| Surgical Treatment | 419 (39%) | 3 (100%) | 254 (96%) | 48 (83%) | 75 (39%) | 36 (6%) | 3 (43%) |
| Radiation Therapy | 413 (38%) | 0 (0%) | 10 (4%) | 8 (14%) | 131 (69%) | 263 (47%) | 1 (14%) |
| Chemotherapy | 522 (48%) | 1 (33%) | 12 (5%) | 41 (71%) | 157 (83%) | 308 (56%) | 3 (43%) |
| Targeted Therapy | 310 (29%) | 0 (0%) | 1 (0%) | 7 (12%) | 24 (13%) | 277 (50%) | 1 (14%) |
| Hormone Therapy | 1 (0.1%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (1%) | 0 (0%) | 0 (0%) |
| Immunotherapy | 11 (1%) | 0 (0%) | 0 (0%) | 0 (0%) | 5 (3%) | 5 (1%) | 1 (14%) |
| Palliative Care | 227 (21%) | 0 (0%) | 0 (0%) | 0 (0%) | 11 (6%) | 215 (39%) | 1 (14%) |
| Bone Marrow/Stem Cell Transplant | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| No Record of Initial Treatment Reported | 3 (0.3%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (1%) | 2 (0%) | 0 (0%) |
Between 2015 and 2019, there were a total of 1,078 analytic lung cancer cases, including 3 patients in stage 0, 265 in stage I, 58 in stage II, 190 in stage III, and 555 in stage IV. In terms of treatment methods, 419 patients (39%) underwent surgical treatment, 413 (38%) received radiation therapy, 522 (48%) underwent chemotherapy, 310 (29%) received targeted therapy, 1 (0.1%) received hormone therapy, 11 (1%) received immunotherapy, 227 (21%) underwent palliative care, and 3 (0.3%) had no record of initial treatment reported.
Five-Year Survival Rates of 1,078 Lung Cancer Patients by Stage (2015-2019)
KFSYSCC’s 2015-2019 five-year observed survival rates for 1,078 lung cancer patients, stratified by stage, are presented in the following chart. As shown in the graph, the five-year survival rate is 100% for stage 0, 91% for stage 1, 71% for stage 2, 35% for stage 3, and 15% for stage 4.